Recent Advances in Extended Ocular Drug Delivery for the Ocular Surface
Molecules · 31.05.2026 · 31 (11) · 1883
DOI: 10.3390/molecules31111883 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 31.05.2026. Verfasst von Yura Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea. Hauptthemen laut MEDLINE: Drug Delivery Systems, Eye, Ophthalmic Solutions, Eye Diseases. Die Arbeit nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Science and ICT.
Abstract (Originalsprache)
The unique anatomy and physiological barriers of the human eye—particularly rapid tear turnover and limited corneal permeability—present significant obstacles to achieving effective topical drug delivery. In response to these constraints, biopolymer-based extended-release systems have emerged as a promising and transformative class of ocular therapeutics. This review provides a comprehensive overview of recent advances in natural biopolymers, including polysaccharides and protein-derived polymers, for application on the ocular surface. These materials exhibit advantageous characteristics such as mucoadhesion, biocompatibility, and stimuli-responsive behavior, which collectively enhance precorneal residence time and enable controlled, sustained drug release. We further discuss diverse delivery platforms—ranging from in situ forming hydrogels and mucoadhesive nanoparticles to drug-eluting contact lenses and microneedle-based systems. In addition, we highlight how the integration of nanotechnology and bioinspired scaffolds can augment the delivery efficiency of therapeutic agents to ocular tissues. Overall, this review underscores the ongoing transition from conventional topical eye drops to sophisticated, functionalized delivery systems capable of maintaining therapeutic drug levels while simultaneously supporting tissue repair and wound healing. Finally, we outline the remaining challenges in clinical translation and consider the future potential of smart, responsive biopolymer systems in advancing the treatment of both anterior and posterior segment diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
ORCID-Profile: Yura Choi
Förderung
- Korea Health Industry Development Institute
- Ministry of Science and ICT
Zitieren
APA
Choi, Y., Jung, M. Y., Han, E., & Park, C. Y. (2026). Recent Advances in Extended Ocular Drug Delivery for the Ocular Surface. Molecules, 31(11), 1883. https://doi.org/10.3390/molecules31111883
Vancouver
Choi Y, Jung MY, Han E, Park CY. Recent Advances in Extended Ocular Drug Delivery for the Ocular Surface. Molecules. 2026;31(11):1883. doi:10.3390/molecules31111883
BibTeX
@article{Choi2026,
author = {Choi, Yura and Jung, Mi-Young and Han, Eunsun and Park, Choul Yong},
title = {Recent Advances in Extended Ocular Drug Delivery for the Ocular Surface},
journal = {Molecules},
year = {2026},
volume = {31},
number = {11},
pages = {1883},
doi = {10.3390/molecules31111883}
}
EUVIMED